Background In patients with angiographically detectable atherosclerosis or in those with risk factors for coronary artery disease, intracoronary acetylcholine causes coronary constriction instead of endothelium-derived relaxing factor-mediated dilation. Therefore, it has been hypothesized that diffuse endothelial dysfunction precedes development of coronary atherosclerosis. We tested this hypothesis in a systematic investigation of the effects of ascending doses of acetylcholine on the diameters of nonstenotic segments of the left coronary artery in patients with advanced atherosclerosis and coronary risk factors.
Background In patients with angiographically detectable atherosclerosis or in those with risk factors for coronary artery disease, intracoronary acetylcholine causes coronary constriction instead of endothelium-derived relaxing factor-mediated dilation. Therefore, it has been hypothesized that diffuse endothelial dysfunction precedes development of coronary atherosclerosis. We tested this hypothesis in a systematic investigation of the effects of ascending doses of acetylcholine on the diameters of nonstenotic segments of the left coronary artery in patients with advanced atherosclerosis and coronary risk factors.
Methods and Results Effects of intracoronary infusion of acetylcholine (10-6 to 10`mol/L) on diameters of proximal, middle, and distal nonstenotic segments of the left coronary artery were studied in 28 consecutive patients with chronic stable angina, positive exercise tests, and angiographic evidence of obstructive atherosclerosis (>50% reduction in lumen diameter in at least one vessel). Two patterns of response to the maximal acetylcholine dose (10-`mol/L) were observed.
In 21 patients (group 1), only constriction was observed in all left anterior descending and circumflex artery segments stud-T he endothelium plays a critical role in modulating vasomotor tone. The vascular effects of acetylcholine on human coronary arteries are complex. Acetylcholine has been shown to cause vasodilation in the presence of an intact endothelium mediated by release of endothelium-derived relaxing factor and to cause vasoconstriction in the absence of functional endothelium by direct stimulation of vascular smooth muscle.1,2 Previous studies have shown that intracoronary acetylcholine infusion causes constriction in patients with obstructive coronary atherosclerosis, even in arteries that appear only minimally irregular angiographically, and dilation in subjects with normal coronary arteries.3-7 On the basis of these findings, it has been proposed that diffuse endothelial dysfunction is present in atherosclerotic coronary arteries. However, pathological studies and, more recently, studies carried ied (16±3%, 19±4%, and 23±4%, respectively; P<.01 compared with control). In 7 other patients (group 2), both constriction and dilation were observed in adjacent segments of the same vessel; maximal acetylcholine dose caused constriction in inic-mediated smooth-muscle constrictor effect is not opposed by acetylcholine-induced release of sufficient endothelium-derived relaxing factor from dysfunctional endothelium. Alternatively, EDRF could be inactivated at sites of dysfunctional endothelium. Conversely, in patients without risk factors for coronary atherosclerosis, acetylcholine causes coronary dilation because the dilating effect of acetylcholine-induced release of endothelium-derived relaxing factor from normal endothelium prevails over direct muscarinic constrictor effects. Our results suggest that the relation between coronary atherosclerosis and endothelial function is much more complex than previously appreciated. We have identified a subset of patients with coronary artery disease risk factors, stable angina, and obstructive coronary atherosclerosis who exhibit both coronary dilation and constriction in response to the same dose of acetylcholine. Of note, constriction and dilation were observed frequently in adjacent segments of the same coronary artery branch. Since these findings were observed in 25% of a population of patients with stable angina and obstructive coronary atherosclerosis, we conclude that the hypothesis that diffuse endothelial dysfunction is an early marker of coronary atherosclerosis may not apply to a sizable proportion of patients with angina. Our results suggest, instead, that there are at least two patterns of endothelial dysfunction: (1) a diffuse pattern involving most vessels throughout their course and (2) a patchy pattern that results in the coexistence of coronary segments with acetylcholineinducible dilatation and of coronary segments with dysfunctional endothelium.
It is worth noting that in our patients with patchy distribution of endothelial dysfunction, we did not observe any apparent consistent relation between the latter and angiographically detectable coronary obstructions. Indeed, as shown in Fig 3A, no constriction in response to acetylcholine was noted at the site of severe stenosis at the mid circumflex artery, while severe constriction that almost totally obliterated the lumen occurred in the angiographically normal proximal segment of the left anterior descending artery.
Since all these patients had one or more risk factors for coronary atherosclerosis, our findings suggest that risk factors per se may not be the only contributor to endothelial dysfunction and that some other factors important to determining the response to acetylcholine exist in certain patients. They also suggest that (1) local factors may be important in determining endothelial dysfunction and (2) the local factors leading to obstructive atherosclerosis may be different, at least in some patients, from those leading to endothelial dysfunction. For example, the endothelium produces vasodilators such as prostacyclin and nitric oxide, as well as vasoconstrictors such as leukotriene (LTC4) and endothelin, and it is also involved in the production of growth factors and inhibitors (for endothelial and smooth muscle cells) and metabolism of circulating substances such as vasoconstrictor catecholamines and platelet products. All these factors are involved in the blood cell/ vessel wall interactions occurring during thrombus formation in patients with unstable angina and myocardial infarction.",2, [19] [20] [21] [22] Possible explanations for the differences between the results of this and previous studies could be related to differences in the methodology used. For instance, some studies3,17 infused acetylcholine subselectively into the left anterior descending artery, which could have obscured any differential change that might have taken place in the other vessel. The use of a bolus injection of acetylcholine instead of continuous infusion in other studies4,5 is another factor to be accounted for. In addition, the time elapsed between end of acetylcholine infusion and angiography is another important factor that has a direct bearing on how much effect remains visualized, depending on the timing of angiography and taking into account the very short half-life of acetylcholine. In our study, this time was not more than 15 seconds.
Yasue et a14 described heterogeneity in the response of coronary arteries to acetylcholine with regard to coronary segments and age of patients. They described 49 patients with angiographically normal coronary arteries, of whom 23 were older than 30 years of age, and 25 patients with atherosclerotic coronary arteries. Acetylcholine constricted most segments of angiographically normal coronary arteries in the older group and also in patients with coronary artery disease. This constrictor response was greater in the proximal than distal segments of both left anterior descending and circumflex arteries. They concluded that proximal segments are more susceptible to endothelial injury or atherosclerosis than distal segments in the coronary arteries. The heterogeneity described by Yasue 
